Description of the methodology used in an ongoing pediatric care interventional study of children born with cleft lip and palate in South America [NCT00097149]

Background: The contribution of birth defects, including cleft lip and palate, to neonatal and infant mortality and morbidity is substantial. As other mortality and morbidity causes including infections, hygiene, prematurity, and nutrition are eradicated in less developed countries, the burden of birth defects will increase proportionally. Methods/Design: We are using cleft lip and palate as a sentinel birth defect to evaluate its burden on neonatal and infant health and to assess the effectiveness of systematic pediatric care during the first month and first two years of life in decreasing this burden. The neonatal intervention, consisting of weekly pediatric evaluation and referral to appropriate care, is delivered to about 696 infants born with cleft lip and/or palate in 47 hospitals in South America. Neonatal mortality in this group will be compared to that in a retrospective control group of about 464 infants born with cleft lip and/or palate in the same hospitals. The subgroup of infants with isolated clefts of both the lip and palate (about 264) is also randomized into two groups, intervened and non-intervened, and further followed up over 2 years. Intervened cases are evaluated by pediatricians every three months and referred for appropriate care. The intervened and non-intervened cases will be compared over study outcomes to evaluate the intervention effectiveness. Non-intervened cases are matched and compared to healthy controls to assess the burden of cleft lip and palate. Outcomes include child's neurological and physical development and family social and economic conditions. Discussion: Large-scale clinical trials to improve infant health in developing countries are commonly suggested, making it important to share the methods used in ongoing studies with other investigators implementing similar research. We describe here the content of our ongoing pediatric care study in South America. We hope that this may help researchers targeting this area to plan their studies more effectively and encourage the development of similar research efforts to target other birth defects or infant outcomes such as prematurity and low birth weight.Instituto Multidisciplinario de Biología Celula

Estimating 3-Dimensional Structure of Tropical Forests from Radar Interferometry / Estimativa da Estrutura 3-Dimensional das Florestas Tropicais Através de Interferometria de Radar

This paper describes the retrieval of 3-dimensional vegetation density profiles from interferometric synthetic aperture radar (InSAR) using physical models. InSAR’s sensitivity to vertical structure is generally regarded as less direct and more difficult to understand than that of lidar. But InSAR’s coverage is superior to that of lidar, suggesting InSAR is more promising as an important component of a global 3-dimensional forest monitoring technique. The goal of this paper is to introduce, simplify and demystify the use of simple physical models to understand InSAR. A general equation expressing the InSAR observation in terms of density is described heuristically, along with the approximations in its development. The information content of the equation leads to the estimation of density parameters. Preliminary results are shown from a multibaseline C-band (wavelength=0.056 m) vertical-polarization interferometer, realized with AirSAR flown at multiple altitudes over primary, secondary, and selectively logged tropical forests, as well as abandoned pastures at La Selva Biological Station in Costa Rica

Estimating 3-Dimensional Structure of Tropical Forests from Radar InterferometryEstimativa da Estrutura 3-Dimensional das Florestas Tropicais Através de Interferometria de Radar

This paper describes the retrieval of 3-dimensional vegetation density profiles from interferometric synthetic aperture radar (InSAR) using physical models. InSAR’s sensitivity to vertical structure is generally regarded as less direct and more difficult to understand than that of lidar. But InSAR’s coverage is superior to that of lidar, suggesting InSAR is more promising as an important component of a global 3-dimensional forest monitoring technique. The goal of this paper is to introduce, simplify and demystify the use of simple physical models to understand InSAR. A general equation expressing the InSAR observation in terms of density is described heuristically, along with the approximations in its development. The information content of the equation leads to the estimation of density parameters. Preliminary results are shown from a multibaseline C-band (wavelength=0.056 m) vertical-polarization interferometer, realized with AirSAR flown at multiple altitudes over primary, secondary, and selectively logged tropical forests, as well as abandoned pastures at La Selva Biological Station in Costa Rica.Resumo Este trabalho descreve o procedimento de recuperação do perfil tridimensional da densidade de vegetação, a partir de dados interferométricos de radar de abertura sintética (InSAR), utilizando modelos físicos. A sensibilidade da técnica InSAR para detectar estruturas verticais de vegetação é geralmente considerada menos direta e mais difícil de entender se comparado com dados de LIDAR (técnica utilizando laser). A utilização da técnica InSAR permite uma cobertura superior ao LIDAR e é potencialmente mais promissora como técnica de monitoramento global para a detecção da estrutura tri-dimensional de florestas. O objetivo deste trabalho é o de simplificar e desmistificar o uso de modelos físicos simples no entendimento da técnica InSAR. A equação geral que expressa a observação InSAR em termos de densidade é escrita heuristicamente, bem como as aproximações feitas no seu desenvolvimento. O conteúdo de informação da equação nos possibilita a estimação dos parâmetros de densidade da vegetação

The effect of systematic pediatric care on neonatal mortality and hospitalizations of infants born with oral clefts

Background: Cleft lip and/or palate (CL/P) increase mortality and morbidity risks for affected infants especially in less developed countries. This study aimed at assessing the effects of systematic pediatric care on neonatal mortality and hospitalizations of infants with cleft lip and/or palate (CL/P) in South America.Methods: The intervention group included live-born infants with isolated or associated CL/P in 47 hospitals between 2003 and 2005. The control group included live-born infants with CL/P between 2001 and 2002 in the same hospitals. The intervention group received systematic pediatric care between the 7 thand 28 thday of life. The primary outcomes were mortality between the 7 thand 28 thday of life and hospitalization days in this period among survivors adjusted for relevant baseline covariates.Results: There were no significant mortality differences between the intervention and control groups. However, surviving infants with associated CL/P in the intervention group had fewer hospitalization days by about six days compared to the associated control group.Conclusions: Early systematic pediatric care may significantly reduce neonatal hospitalizations of infants with CL/P and additional birth defects in South America. Given the large healthcare and financial burden of CL/P on affected families and the relatively low cost of systematic pediatric care, improving access to such care may be a cost-effective public policy intervention.Instituto Multidisciplinario de Biología Celula

The effect of systematic pediatric care on neonatal mortality and hospitalizations of infants born with oral clefts

<p>Abstract</p> <p>Background</p> <p>Cleft lip and/or palate (CL/P) increase mortality and morbidity risks for affected infants especially in less developed countries. This study aimed at assessing the effects of systematic pediatric care on neonatal mortality and hospitalizations of infants with cleft lip and/or palate (CL/P) in South America.</p> <p>Methods</p> <p>The intervention group included live-born infants with isolated or associated CL/P in 47 hospitals between 2003 and 2005. The control group included live-born infants with CL/P between 2001 and 2002 in the same hospitals. The intervention group received systematic pediatric care between the 7^thand 28^thday of life. The primary outcomes were mortality between the 7^thand 28^thday of life and hospitalization days in this period among survivors adjusted for relevant baseline covariates.</p> <p>Results</p> <p>There were no significant mortality differences between the intervention and control groups. However, surviving infants with associated CL/P in the intervention group had fewer hospitalization days by about six days compared to the associated control group.</p> <p>Conclusions</p> <p>Early systematic pediatric care may significantly reduce neonatal hospitalizations of infants with CL/P and additional birth defects in South America. Given the large healthcare and financial burden of CL/P on affected families and the relatively low cost of systematic pediatric care, improving access to such care may be a cost-effective public policy intervention.</p> <p>Trial Registration</p> <p>ClinicalTrials.gov: <a href="http://www.clinicaltrials.gov/ct2/show/NCT00097149">NCT00097149</a></p

Description of the methodology used in an ongoing pediatric care interventional study of children born with cleft lip and palate in South America [NCT00097149]

BACKGROUND: The contribution of birth defects, including cleft lip and palate, to neonatal and infant mortality and morbidity is substantial. As other mortality and morbidity causes including infections, hygiene, prematurity, and nutrition are eradicated in less developed countries, the burden of birth defects will increase proportionally. METHODS/DESIGN: We are using cleft lip and palate as a sentinel birth defect to evaluate its burden on neonatal and infant health and to assess the effectiveness of systematic pediatric care during the first month and first two years of life in decreasing this burden. The neonatal intervention, consisting of weekly pediatric evaluation and referral to appropriate care, is delivered to about 696 infants born with cleft lip and/or palate in 47 hospitals in South America. Neonatal mortality in this group will be compared to that in a retrospective control group of about 464 infants born with cleft lip and/or palate in the same hospitals. The subgroup of infants with isolated clefts of both the lip and palate (about 264) is also randomized into two groups, intervened and non-intervened, and further followed up over 2 years. Intervened cases are evaluated by pediatricians every three months and referred for appropriate care. The intervened and non-intervened cases will be compared over study outcomes to evaluate the intervention effectiveness. Non-intervened cases are matched and compared to healthy controls to assess the burden of cleft lip and palate. Outcomes include child's neurological and physical development and family social and economic conditions. DISCUSSION: Large-scale clinical trials to improve infant health in developing countries are commonly suggested, making it important to share the methods used in ongoing studies with other investigators implementing similar research. We describe here the content of our ongoing pediatric care study in South America. We hope that this may help researchers targeting this area to plan their studies more effectively and encourage the development of similar research efforts to target other birth defects or infant outcomes such as prematurity and low birth weight

Clinical Epidemiology Of Skeletal Dysplasias In South America

Currently accepted birth prevalence for osteochondrodysplasias (OCD) of about 2/10,000 is based on few studies from small series of cases. We conducted a study based on more than 1.5 million births. OCD cases were detected from 1,544,496 births occurring and examined in 132 hospitals of ECLAMC (Latin American Collaborative Study of Congenital Malformations) between 2000 and 2007. Cases were detected and registered according to a pre-established protocol, and then ranked in four diagnostic evidence levels (DEL), according to available documentation. For the analysis of risk factors, a healthy control sample born in the same period was used. OCD was diagnosed in 492 newborns, resulting in a prevalence per 10,000 of 3.2 (95% CI: 2.9-3.5). Perinatal lethality (stillbirths plus early neonatal deaths) occurred in 50% of cases. Prenatal ultrasound diagnosis was made in 73% of cases (n=359). Among 211 cases from the best documented group (DEL-1) and according to international classification, 33% of cases fit into the G-25 (osteogenesis imperfecta), 29% in Group-1 (FGFR3), and 8% in Group-18 (Bent bones). The prevalence of the main OCD types were: OI-0.74 (0.61-0.89); thanatophoric dysplasia-0.47 (0.36-0.59); and achondroplasia-0.44 (0.33-0.55). Paternal age (31.2±8.5), parity (2.6), and parental consanguinity rate (5.4%) were higher in cases than in controls (P<0.001). In conclusion, the OCD overall prevalence of 3.2 per 10,000 found seems to be more realistic than previous estimates. This study also confirmed the high perinatal mortality, and the association with high paternal age, parity, and parental consanguinity rate. © 2012 Wiley Periodicals, Inc.158 A510381045Al-Gazali, L.I., Bakir, M., Hamid, Z., Varady, E., Varghes, M., Haas, D., Bener, A., Dawodu, A.K., Birth prevalence and pattern of osteochondrodysplasias in an inbred high risk population (2003) Birth Defects Res Part A, 67, pp. 125-132Andersen Jr, P.E., Prevalence of lethal osteochondrodysplasias in Denmark (1989) Am J Med Genet, 32, pp. 484-489Andersen Jr, P.E., Hauge, M., Congenital generalized bone dysplasias: A clinical, radiological, and epidemiological survey (1989) J Med Genet, 27, pp. 37-44Baldridge, D., Schwarze, U., Morello, R., Lennington, J., Bertin, T.K., Pace, J.M., Pepin, M.G., Lee, B., CRTAP and LEPRE1 mutations in recessive osteogenesis imperfecta (2008) Hum Mut, 0, pp. 1-8Barnes, A.M., Carter, E.M., Cabral, W.A., Weis, M., Chang, W., Makareeva, E., Leikin, S., Marini, J.C., Lack of cyclophilin B in osteogenesis imperfecta with normal collagen folding (2010) N Engl J Med, 362, pp. 521-528Camera, G., Mastroiacovo, P., Birth prevalence of skeletal dysplasias in the Italian multicentric monitoring system for birth defects (1982) Prog Clin Biol Res, 104, pp. 441-449Castilla, E.E., Orioli, I.M., ECLAMC: The Latin-American Collaborative Study of Congenital Malformations (2004) Community Genet, 7, pp. 76-94Cavalcanti, D.P., Huber, C., Sang, K.H., Baujat, G., Collins, F., Delezoide, A., Dagoneau, N., Cormier-Daire, V., Mutation in IFT80 in a foetus with a phenotype of Verma-Naumoff provides molecular evidence for the Jeune-Verma-Naumoff dysplasia spectrum (2011) J Med Genet, 48, pp. 88-92Cobben, J.M., Cornel, M.C., Dijkstra, I., ten Kate, L.P., Prevalence of lethal osteochondrodysplasias (1990) Am J Med Genet, 36, pp. 377-378Connor, J.M., Connor, R.A.C., Sweet, E.M., Gibson, A.A.M., Patrick, W.J.A., McNay, M.B., Redford, D.H.A., Lethal neonatal chondrodysplasias in the west of Scotland 1970-1983 with a description of a thanatophoric, dysplasia like, autosomal recessive disorder, Glasgow variant (1985) Am J Med Genet, 22, pp. 243-253Furuichi, T., Kayserili, H., Hiraoka, S., Nishimura, G., Ohashi, H., Alanay, Y., Lerena, J.C., Ikegawa, S., Identification of loss-of-function mutations of SLC35D1 in patients with Schneckenbecken dysplasia, but not with other severe spondylodysplastic dysplasias group diseases (2009) J Med Genet, 46, pp. 562-568Gustavson, K.H., Jorulf, H., Different types of osteochondrodysplasia in a consecutive series of newborns (1975) Helv Pediat Acta, 30, pp. 307-314Hall, J.G., Allanson, J.E., Gripp, K.W., Slavotinek, A.M., (1989) Handbook of physical measurements, , 1st edition. New York: Oxford University PressHuber, C., Oulès, B., Bertoli, M., Chami, M., Alanay, M.F.Y., Al-Gazali, L.I., Ausems, M.G.E.M., Cormier-Daire, V., Identification of CANT1 mutations in Desbuquois dysplasia (2009) Am J Hum Genet, 85, pp. 706-710Källén, B., Knudsen, L.B., Mutchinick, O., Mastroiacovo, P., Lancaster, P., Castilla, E., Robert, E., Monitoring dominant germ cell mutations using skeletal dysplasias registered in malformation registries: An International Feasibility Study (1993) Int J Epidemiol, 22, pp. 107-115Krakow, D., Williams III, J., Poehl, M., Rimoin, D.L., Platt, D.L., Use of tridimensional ultrasound imaging in the diagnosis of prenatal-onset skeletal dysplasia (2003) Ultrasound Obstet Gynecol, 21, pp. 467-472Krakow, D., Lachman, R.S., Rimoin, D.L., Guidelines for the prenatal diagnosis of fetal skeletal dysplasias (2009) Genet Med, 11, pp. 127-133Lachman, R.S., (2007) Taybi and Lachman's radiology of syndromes, metabolic disorders and skeletal dysplasias, , 5th edition. Philadelphia, PA: Mosby ElsevierLecora, M., Parenti, G., Iaccarino, E., Scarano, G., Cucchiara, S., Andria, G., Immunological disorder and Hirschsprung disease in round femoral inferior epiphysis dysplasia (1995) Clin Dysmorphol, 4, pp. 130-135Liascovich, R., Castilla, E.E., Rattler, M., Consanguinity in South America: Demographic aspects (2001) Hum Hered, 51, pp. 27-34Oberklaid, F., Danks, D.M., Jensen, F., Stace, L., Rosshandler, S., Achondroplasia and hypochondroplasia. Comments on frequency, mutation rates and radiological features in skull and spine (1979) J Med Genet, 16, pp. 140-146Orioli, I.M., Castilla, E.E., Barbosa-Neto, J.G., The birth prevalence rates for the skeletal dysplasias (1986) J Med Genet, 23, pp. 328-332Orioli, I.M., Castilla, E.E., Scarano, G., Mastroiacovo, P., Effect of paternal age in achondroplasia, thanatophoric dysplasia, and osteogenesis imperfecta (1995) Am J Med Genet, 59, pp. 209-217Otto, P.A., (2008), Genética de poblaciones humanas. 1a ed. Posadas EdUNaM-Editorial Universitaria de la Universidad Nacional de MisionesRasmussen, S.A., Bieber, B.R., Benacerraf, B.R., Lachman, R.S., Rimoin, D.L., Holmes, L.B., Epidemiology of osteochondrodysplasias: Changing trends due to advances in prenatal diagnosis (1996) Am J Med Genet, 61, pp. 49-58Reis, F.C., Alexandrino, F., Steiner, C.E., Norato, D.Y.J., Cavalcanti, D.P., Sartorato, E.L., Molecular findings in Brazilian patients with osteogenesis imperfecta (2005) J Appl Genet, 46, pp. 105-108Rohlf, F.J., Sokal, R.R., (1995) Statistical tables, , 3rd edition. San Francisco, CA: FreemanSánchez, O., Brito-Arreaza, A., Alvarez-Arratia, M.C., Ramírez, N., Prevalencia de displasias esqueléticas em recién nacidos en el Hospital Ruíz y Páez de Ciudad Bolívar. Venezuela. Período 1978-1990 (1991) Invest Clin, 32, pp. 67-76Spranger, J., Maroteaux, P., The lethal osteochondrodysplasias (1990) Adv Hum Genet, 19, pp. 1-103Spranger, J.W., Brill, P.W., Poznanski, A., (2002) Bone dysplasias, , 2nd edition. New York: Oxford University PressStoll, C., Dott, B., Roth, M.P., Alembik, Y., Birth prevalence rates of skeletal dysplasias (1989) Clin Genet, 35, pp. 88-92Superti-Furga, A., Unger, S., Nosology and classification of genetic skeletal disorders: 2006 revision (2007) Am J Med Genet Part A, 143 A, pp. 1-18Unger, S., Superti-Furga, A., Rimoin, D.L., A diagnostic approach to skeletal dysplasia. Chapter 16. (2003) Pediatric bone diseases, pp. 375-400. , Glorieux F, Juppner H, editors. San Diego, CA: ElsevierWaller, D.K., Correa, A., Vo, T.M., Wang, Y., Hobbs, C., Langlois, P.H., Pearson, K., Hecht, J.T., The population-based prevalence of achondroplasia and thanatophoric dysplasia in selected regions of the US (2008) Am J Med Genet Part A, 146 A, pp. 2385-2389Warman, M.L., Cormier-Daire, V., Hall, C., Krakow, D., Lachman, R., LeMerrer, M., Mortier, G., Superti-Furga, A., Nosology and classification of genetic skeletal disorders: 2010 revision (2011) Am J Med Genet Part A, 155 A, pp. 943-96

Revisiting the putative role of heme as a trigger of inflammation

Activation of the innate immune system by free heme has been proposed as one of the principal consequences of cell-free hemoglobin (Hb) exposure. Nonetheless, in the absence of infection, heme exposures within a hematoma, during hemolysis, or upon systemic administration of Hb (eg, as a Hb-based oxygen carrier) are typically not accompanied by uncontrolled inflammation, challenging the assumption that heme is a major proinflammatory mediator in vivo. Because of its hydrophobic nature, heme liberated from oxidized hemoglobin is rapidly transferred to alternative protein-binding sites (eg, albumin) or to hydrophobic lipid compartments minimizing protein-free heme under in vivo equilibrium conditions. We demonstrate that the capacity of heme to activate human neutrophil granulocytes strictly depends on the availability of non protein-associated heme. In human endothelial cells as well as in mouse macrophage cell cultures and in mouse models of local and systemic heme exposure, protein-associated heme or Hb do not induce inflammatory gene expression over a broad range of exposure conditions. Only experiments in protein-free culture medium demonstrated a weak capacity of heme-solutions to induce toll-like receptor-(TLR4) dependent TNF-alpha expression in macrophages. Our data suggests that the equilibrium-state of free and protein-associated heme critically determines the proinflammatory capacity of the metallo-porphyrin. Based on these data it appears unlikely that inflammation-promoting equilibrium conditions could ever occur in vivo